Literature DB >> 4614049

Cytotoxic antibody activity in measles and subacute sclerosing panencephalitis (SSPE) infection.

R Kibler, A Deller, V ter Meulen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4614049     DOI： 10.1007/bf02121725

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  17 in total

1.  Immunopathological aspects in the pathogenesis of subacute sclerosing panencephalitis, with special reference to the significance of the immune response in the central nervous system.

Authors:  B Vandvik
Journal:  Ann Clin Res       Date:  1973-10

2.  Measles-virus antibody and antigen in subacute sclerosing panencephalitis.

Authors:  J H Connolly; I V Allen; L J Hurwitz; J H Millar
Journal:  Lancet       Date:  1967-03-11       Impact factor: 79.321

3.  Production of antibody by the central nervous system in subacute sclerosing panencephalitis.

Authors:  R W Cutler; E Merler; J P Hammerstad
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

4.  Subacute sclerosing panencephalitis: brain immunoglobulin-G, measles antibody and albumin.

Authors:  W W Tourtellotte; J A Parker; R M Herndon; C V Cuadros
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

5.  Immunhistological, microscopical and neurochemical studies on encephalitides. 3. Subacute progressive panencephalitis. Virological and immunhistological studies.

Authors:  V ter Muelen; G Enders-Ruckle; D Müller; G Joppich
Journal:  Acta Neuropathol       Date:  1969       Impact factor: 17.088

6.  Immunoglobulins and measles antibodies in subacute sclerosing panencephalitis.

Authors:  H Link; M Panelius; A A Salmi
Journal:  Arch Neurol       Date:  1973-01

7.  Immune lysis of rabies virus-infected cells.

Authors:  T J Wiktor; E Kuwert; H Koprowski
Journal:  J Immunol       Date:  1968-12       Impact factor: 5.422

8.  Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

9.  Studies on the persistent infection with measles virus in HeLa cells. 3. Immunolysis of cells in carrier state by anti-measles sera.

Authors:  T Minagawa; M Yamada
Journal:  Jpn J Microbiol       Date:  1971-07

10.  Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis.

Authors:  A A Salmi; E Norrby; M Panelius
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441
View more
  3 in total

1.  Complications and immunological studies of measles virus infection in antithymocyte-treated hamsters.

Authors:  N E Cremer; S J Hagens; D O Taylor; E H Lennette
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

2.  Demonstration of HLA restricted killer cells in patients with acute measles.

Authors:  H W Kreth; V ter Meulen; G Eckert
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

3.  Complement dependen cytotoxic antibody activity against measles virus in multiple sclerosis.

Authors:  V Kratzsch; W R Kiessling
Journal:  J Neurol       Date:  1977-08-18       Impact factor: 4.849
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.